Literature DB >> 7562786

Assessing the cost effectiveness of NSAID: an international perspective.

M Drummond1, M B Ferraz, J Mason.   

Abstract

A number of factors may affect the cost effectiveness of treatments and can cause this to vary by location. These factors include the patient population, relative price levels, clinical practice patterns and incentives to health professionals and institutions such as hospitals. This paper illustrates these issues by assessing the relative cost effectiveness of 3 nonsteroidal antiinflammatory drugs (NSAID), with different levels of gastrointestinal side effects, in 3 countries. We conclude that the relative cost effectiveness of drugs is not only dependent on drug price but may also vary by country.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7562786

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  7 in total

1.  A decision chart for assessing and improving the transferability of economic evaluation results between countries.

Authors:  Robert Welte; Talitha Feenstra; Hans Jager; Reiner Leidl
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

2.  The art versus the science of medicine. Are clinical practice guidelines the answer?

Authors:  M E Suarez-Almazor; A S Russell
Journal:  Ann Rheum Dis       Date:  1998-02       Impact factor: 19.103

Review 3.  Economic evaluation of the management of pain in osteoarthritis.

Authors:  P Tugwell
Journal:  Drugs       Date:  1996       Impact factor: 9.546

4.  The cost effectiveness of tapered versus abrupt discontinuation of oral cyclosporin microemulsion for the treatment of psoriasis.

Authors:  L Hakkaart-van Roijen; P Verboom; W K Redekop; K R Touw; F F Rutten
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

5.  Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthma.

Authors:  M P Rutten-van Mölken; E K van Doorslaer; M D Till
Journal:  Pharmacoeconomics       Date:  1998-12       Impact factor: 4.981

6.  Musculoskeletal pain: prescription of NSAID and weak opioid by primary health care physicians in Sweden 2004-2008 - a retrospective patient record review.

Authors:  Metha Brattwall; Ibrahim Turan; Jan Jakobsson
Journal:  J Pain Res       Date:  2010-08-04       Impact factor: 3.133

Review 7.  Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis.

Authors:  Beverley Shea; Michael V Swinden; Elizabeth Tanjong Ghogomu; Zulma Ortiz; Wanruchada Katchamart; Tamara Rader; Claire Bombardier; George A Wells; Peter Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2013-05-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.